0001225208-12-016952.txt : 20120801
0001225208-12-016952.hdr.sgml : 20120801
20120801115312
ACCESSION NUMBER: 0001225208-12-016952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120730
FILED AS OF DATE: 20120801
DATE AS OF CHANGE: 20120801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOUTHWELL DAVID P
CENTRAL INDEX KEY: 0001251553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14169
FILM NUMBER: 12999092
MAIL ADDRESS:
STREET 1: 350 MAIN ST
CITY: CONCORD
STATE: MA
ZIP: 01742
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC
CENTRAL INDEX KEY: 0000901219
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223178468
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14200 SHADY GROVE ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850-3338
BUSINESS PHONE: 3013098504
MAIL ADDRESS:
STREET 1: 14200 SHADY GROVE ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
X0306
4
2012-07-30
1
0000901219
HUMAN GENOME SCIENCES INC
HGSI
0001251553
SOUTHWELL DAVID P
14200 SHADY GROVE ROAD
ROCKVILLE
MD
20850
1
Chief Financial Officer
Common Stock
2012-07-30
4
U
0
90835.0000
14.2500
D
0.0000
D
Employee Stock Option - Right to Buy
8.2300
2012-07-30
4
D
0
108000.0000
14.2500
D
2022-03-10
Common Stock
108000.0000
0.0000
D
This option was cancelled in the tender offer that expired on July 27, 2012 in exchange for a cash payment of $650,160.00, representing the difference between the exercise price of the option and the offer price ($14.25 per share) pursuant to the Merger Agreement between the issuer and GlaxoSmithKline plc.These options vested automatically upon consummation of the tender offer on July 30, 2012.
/s/ David Southwell
2012-07-30